| Bioactivity | VPC-80051 is an inhibitor of hnRNP A1 splicing activity. VPC-80051 directly interacts with hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line. VPC-80051 can be used in prostate cancer research[1]. |
| CAS | 2410979-04-1 |
| Formula | C16H13F2N3O |
| Molar Mass | 301.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Carabet LA, et al. Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer. Molecules. 2019 Feb 20;24(4):763. |
VPC-80051
CAS: 2410979-04-1 F: C16H13F2N3O W: 301.29
VPC-80051 is an inhibitor of hnRNP A1 splicing activity. VPC-80051 directly interacts with hnRNP A1 RBD and reduces AR-V
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.